Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion type Assertion NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_head.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion wasGeneratedBy ECO_0000203 NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_provenance.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion wasDerivedFrom befree-20150227 NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_provenance.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion SIO_000772 19864236 NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_provenance.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion evidence source_evidence_literature NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_provenance.
- NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873606.RAwQdsK6FfG1K256r7fXOYwhu7baOgOqX-YGcqTQ-Q0LM130_provenance.